(Q33920998)

30 July 2017

1 reference

title

The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review (English)

1 reference

30 July 2017

0 references

1 reference

schizophrenic psychology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1349823

17 September 2022

author name string

C. Simhandl

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1349823

17 September 2022

K. Meszaros

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1349823

17 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1349823

17 September 2022

publication date

1 March 1992

1 reference

full work available at URL

30 July 2017

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1349823/pdf/?tool=EBI

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1349823

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1349823/?tool=EBI

17 September 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1349823

https://europepmc.org/articles/PMC1188379

17 September 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1349823

https://europepmc.org/articles/PMC1188379?pdf=render

17 September 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1349823

Journal of Psychiatry & Neuroscience

17 September 2022

published in

1 reference

30 July 2017

volume

17

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

1-14

1 reference

A rating scale for depression

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

The diagnostic interview for borderline patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine versus propranolol in patients with uncontrolled rage outbursts: a random assignment study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Treatment of resistant lithium-induced nephrogenic diabetes insipidus and schizoaffective psychosis with carbamazepine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Case report of a possible interaction between neuroleptics and carbamazepine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Interactions of carbamazepine with benzodiazepine receptors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Lithium Treatment in Schizophrenia and Schizo-Affective Disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine in the psychiatric patient

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine in treatment of violent schizophrenics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

A rating scale for extrapyramidal side effects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

The effects of carbamazepine on patients with psychomotor epilepsy: results of a double-blind study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine in mixed frontal lobe and psychiatric disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

A haloperidol-carbamazepine interaction in a patient with rapid-cycling bipolar disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Haloperidol plasma levels and clinical response: basic concepts and clinical data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Alternative therapies for bipolar disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine and lithium: different profiles in affective disorder?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Efficacy of adjunctive carbamazepine in the treatment of chronic schizophrenia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Review of haloperidol blood level and clinical response: looking through the window

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

A case of organic brain syndrome following head injury successfully treated with carbamazepine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Open clinical trial of carbamazepine in chronic schizophrenic inpatients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Dextro-amphetamine diminishes negative symptoms in schizophrenia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine in nonresponsive psychosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Plasma concentrations of haloperidol and prolactin and clinical outcome in acutely psychotic patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

The significance of depression in the prediction of relapse in chronic schizophrenia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine in the treatment of aggression: a case report and a review of the literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Is there a common denominator for the antimanic effect of lithium and anticonvulsants?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Antidepressant withdrawal syndromes: phenomenology and pathophysiology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Plasma level monitoring of antipsychotic drugs. Clinical utility

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine in tardive dyskinesia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Antipsychotic drug side effects: their relationship to dose

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

The clinical uses and pharmacology of carbamazepine in psychiatry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Clinical efficacy of carbamazepine in affective, schizoaffective, and schizophrenic disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Clinical issues in the use of carbamazepine in psychiatry: a review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Alternatives to lithium for preventive treatment of bipolar disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine maintenance treatment in outpatient schizophrenics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Behavioral effects of carbamazepine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Anticonvulsants in the treatment of aggression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Thymoleptic and neuroleptic drug plasma levels in psychiatry: current status

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine in the dyscontrol syndrome associated with limbic system dysfunction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Cocaine, kindling, and psychosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Acute high-dose parenteral haloperidol treatment of psychosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Antipsychotic effects of lithium in schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Therapeutic effects of carbamazepine in affective illness: a preliminary report

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

A rating scale for tardive dyskinesia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Lithium in chronic schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Telemetered EEG-EOG During Psychotic Behaviors of Schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Plasma Level Monitoring of Antipsychotic Drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Maintenance antipsychotic therapy: is the cure worse than the disease?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Evidence of ten psychotic syndromes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

A purinergic component in the anticonvulsant action of carbamazepine?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Detection of RNA complementary to herpes simplex virus in human oral squamous cell carcinoma

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Development of melancholia during carbamazepine treatment in borderline personality disorder

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Decreased episodic violence and increased control of dissociation in a carbamazepine-treated case of multiple personality

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188379

Impact of lithium therapy on core psychotic symptoms of schizophrenia

29 October 2018

1 reference

12 December 2020

Carbamazepine in violent non-epileptic schizophrenics

1 reference

12 December 2020

Is carbamazepine helpful in paroxysmal behavior disorders?

1 reference

12 December 2020

Effect of anticonvulsants on plasma haloperidol and thioridazine levels

1 reference

12 December 2020

Carbamazepine treatment of selected affectively disordered inpatients

1 reference

12 December 2020

Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients

1 reference

12 December 2020

Kindling-induced experimental epilepsy in rats: Cortical stimulation

1 reference

12 December 2020

Carbamazepine in manic-depressive illness: a new treatment

1 reference

12 December 2020

STUDIES ON A NEW ANTI-EPILEPTIC AGENT

1 reference

12 December 2020

Treatment of acute schizophrenia with ultra-high-dose fluphenazine: A failure at shortening time on a crisis-intervention unit

1 reference

12 December 2020

Mood disorders in the psychoneurologic borderland: three cases of responsiveness to carbamazepine

1 reference

12 December 2020

Effects of carbamazepine on dopamine function in rodents

1 reference

12 December 2020

Carbamazepine in the treatment of tardive dyskinesia

1 reference

12 December 2020

The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients

1 reference

12 December 2020

Carbamazepine as an adjunct of antipsychotic therapy

1 reference

12 December 2020

Carbamazepine in the treatment of catatonia

1 reference

12 December 2020

Carbamazepine in rapid cycling bipolar affective disorder

1 reference

12 December 2020

Neuroleptic malignant syndrome

1 reference

12 December 2020

The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia

1 reference

12 December 2020

Dopaminergic effects of carbamazepine. Relationship to clinical response in affective illness

1 reference

12 December 2020

Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia

1 reference

12 December 2020

Depressive symptoms in acute schizophrenic hospitalized patients

1 reference

12 December 2020

Further studies with propranolol in psychotic patients. Relation to initial psychiatric state, urinary catecholamines and 3-methoxy-4-hydroxyphenylglycol excretion

1 reference

12 December 2020

Studies on the psychotropic action of Tegretol

1 reference

12 December 2020

Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients

1 reference

12 December 2020

Lithium withdrawal trial in chronic schizophrenia

1 reference

12 December 2020

Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study

1 reference

12 December 2020

Clinical response and plasma haloperidol levels in schizophrenia

1 reference

12 December 2020

Response of functional hallucinations to carbamazepine

1 reference

12 December 2020

Biochemical mechanisms of action of carbamazepine in affective illness and epilepsy

1 reference

12 December 2020

Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics

1 reference

12 December 2020

Carbamazepine in the treatment of aggressive behavior in schizophrenic patients: a case report

1 reference

12 December 2020

High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin

1 reference

12 December 2020

Second International Congress on Schizophrenia Research. San Diego, California, April 1-5, 1989. Abstracts

1 reference

12 December 2020

Orofacial dyskinesia, cognitive function and medication

1 reference

12 December 2020

1 reference

12 December 2020

A carbamazepine trial in chronic, treatment-refractory schizophrenia

1 reference

12 December 2020

Carbamazepine versus lithium in mania: a double-blind study

1 reference

12 December 2020

An open clinical trial of carbamazepine in treatment-resistant bipolar and schizo-affective psychotics

1 reference

12 December 2020

Effect of carbamazepine on neuroleptic plasma levels and efficacy

1 reference

12 December 2020

Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?

1 reference

12 December 2020

Effects of carbamazepine on plasma haloperidol levels

1 reference

12 December 2020

Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy

1 reference

12 December 2020

A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness

1 reference

12 December 2020

A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients

1 reference

12 December 2020

Carbamazepine in the treatment of psychotic and behavioral disorders. A pilot study

1 reference

12 December 2020

Relationship of serum haloperidol levels to clinical response in schizophrenic patients

1 reference

12 December 2020

Identifiers

PMC publication ID

1188379

1 reference

30 July 2017

1 reference